This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Cauda luminal fluid
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Fetal human colon epithelial cell (FHC)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Mast cell (HMC-1)
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Pancreatic cancer cells (AsPC1, BxPC3, Capan1, Capan2, MiaPaca2, Panc1, Pt45P1, A818, Colo357, HD3577)
Serum
T cell (Jurkat)
By sample status
24 hr culture
72 hr culture
Colorectal cancer_stage2_after_resection
Colorectal cancer_stage3a
Colorectal cancer_stage3b_after_resection
Colorectal cancer_stage4_after_resection
Fetal bovine serum
Healthy_timepoint1
Healthy_timepoint2
Normal
Normal_Agilent
Normal_Exiqon
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Pollen allergy_timepoint2
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-765
MIMAT0003945
0.0e+0
1.3e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
1.3e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
6.3e-2
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
7.9e-2
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
3.3e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
9.4e-5
4.5e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
1.3e-5
4.3e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
4.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
4.8e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
2.3e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
1.0e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
1.6e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
ppy-miR-765
MIMAT0016105
0.0e+0
3.2e-9
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
3.3e-10
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
ppy-miR-765
MIMAT0016105
0.0e+0
3.1e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
2.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
2.9e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
3.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
ppy-miR-765
MIMAT0016105
0.0e+0
2.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
mml-miR-765
MIMAT0006509
0.0e+0
1.4e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
2.3e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
2.7e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
4.0e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
5.0e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
0.0e+0
1.7e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
8.5e-3
8.5e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000545_1
47
/
0
/
47
hsa-miR-765
MIMAT0003945
9.0e-3
9.0e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000545_1
47
/
0
/
47
<
[2]